Publications 2021

Bergo KK, Larstorp AC, Hoffmann P, Hjornholm U, Cataliotti A, Hoieggen A, Rostrup M, Elmula FEMF (2021)
Renal sympathetic denervation lowers systemic vascular resistance in true treatment-resistant hypertension
Blood Pressure, 30 (1), 31-40
DOI 10.1080/08037051.2020.1789446

da Silva GJJ, Altara R, Booz GW, Cataliotti A (2021)
Atrial Natriuretic Peptide(31-67): A Novel Therapeutic Factor for Cardiovascular Diseases
Front. Physiol., 12, 691407
DOI 10.3389/fphys.2021.691407

Frisk M, Le C, Shen X, Roe AT, Hou YF, Manfra O, Silva GJJ, van Hout I, Norden ES, Aronsen JM, Laasmaa M, Espe EKS, Zouein FA, Lambert RR, Dahl CP, Sjaastad I, Lunde IG, Coffey S, Cataliotti A, Gullestad L, Tonnessen T, Jones PP, Altara R, Louch WE (2021)
Etiology-Dependent Impairment of Diastolic Cardiomyocyte Calcium Homeostasis in Heart Failure With Preserved Ejection Fraction
J. Am. Coll. Cardiol., 77 (4), 405-419
DOI 10.1016/j.jacc.2020.11.044

Kaplan A, Altara R, Manca M, Gunes HM, Cataliotti A, Booz GW, Zouein FA (2021)
Distorted assessment of left atrial size by echocardiography in patients with increased aortic root diameter
Egypt. Heart J., 73 (1), 55
DOI 10.1186/s43044-021-00177-2

Norden ES, Bendiksen BA, Andresen H, Bergo KK, Espe EK, Hasic A, Hauge-Iversen IM, Veras I, Hussain RI, Sjaastad I, Christensen G, Cataliotti A (2021)
Sacubitril/valsartan ameliorates cardiac hypertrophy and preserves diastolic function in cardiac pressure overload
ESC Heart Fail., 8 (2), 918-927
DOI 10.1002/ehf2.13177

Publications 2020

Altara R, da Silva GJJ, Frisk M, Spelta F, Zouein FA, Louch WE, Booz GW, Cataliotti A (2020)
Cardioprotective Effects of the Novel Compound Vastiras in a Preclinical Model of End-Organ Damage
Hypertension, 75 (5), 1195-1204
DOI 10.1161/HYPERTENSIONAHA.120.14704

Publications 2019

Roe AT, Ruud M, Espe EK, Manfra O, Longobardi S, Aronsen JM, Norden ES, Husebye T, Kolstad TRS, Cataliotti A, Christensen G, Sejersted OM, Niederer SA, Andersen GO, Sjaastad I, Louch WE (2019)
Regional diastolic dysfunction in post-infarction heart failure: role of local mechanical load and SERCA expression
Cardiovasc. Res., 115 (4), 752-764
DOI 10.1093/cvr/cvy257

Publications 2018

Altara R, Ghali R, Mallat Z, Cataliotti A, Booz GW, Zouein FA (2018)
Conflicting vascular and metabolic impact of the IL-33/sST2 axis
Cardiovasc. Res., 114 (12), 1578-1594
DOI 10.1093/cvr/cvy166

Altara R, Zouein FA, Brandao RD, Bajestani SN, Cataliotti A, Booz GW (2018)
In Silico Analysis of Differential Gene Expression in Three Common Rat Models of Diastolic Dysfunction
Front. Cardiovasc. Med., 5, 11
DOI 10.3389/fcvm.2018.00011

Ghali R, Altara R, Louch WE, Cataliotti A, Mallat Z, Kaplan A, Zouein FA, Booz GW (2018)
IL-33 (Interleukin 33)/sST2 (Soluble Suppression of Tumorigenicity 2) Axis in Hypertension and Heart Failure
Hypertension, 72 (4), 818-828
DOI 10.1161/HYPERTENSIONAHA.118.11157

Kolstad TR, van den Brink J, MacQuaide N, Lunde PK, Frisk M, Aronsen JM, Norden ES, Cataliotti A, Sjaastad I, Sejersted OM, Edwards AG, Lines GT, Louch WE (2018)
Ryanodine receptor dispersion disrupts Ca2+ release in failing cardiac myocytes
eLife, 7, e39427
DOI 10.7554/eLife.39427

Publications 2017

Altara R, Giordano M, Norden ES, Cataliotti A, Kurdi M, Bajestani SN, Booz GW (2017)
Targeting Obesity and Diabetes to Treat Heart Failure with Preserved ejection Fraction
Front. Endocrinol., 8, 160
DOI 10.3389/fendo.2017.00160

Giordano M, Ciarambino T, Castellino P, Malatino L, Cataliotti A, Rinaldi L, Paolisso G, Adinolfi LE (2017)
Seasonal variations of hyponatremia in the emergency department: Age-related changes
Am. J. Emerg. Med., 35 (5), 749-752
DOI 10.1016/j.ajem.2017.01.018

Holditch SJ, Schreiber CA, Harris PC, LaRusso NF, Ramirez-Alvarado M, Cataliotti A, Torres VE, Ikeda Y (2017)
B-type natriuretic peptide overexpression ameliorates hepatorenal fibrocystic disease in a rat model of polycystic kidney disease
Kidney Int., 92 (3), 657-668
DOI 10.1016/j.kint.2017.02.017

Publications 2016

Buonacera A, Boukhris M, Tomasello SD, Campagna A, Cilia C, Tripepi G, Di Marca S, Terranova V, Pisano M, Mastrosimone G, Galassi AR, Stancanelli B, Cataliotti A, Malatino L (2016)
Impact of left ventricular remodeling and renal function on 24 h-ECG recordings and cardiovascular outcome in elderly hypertensive patients
Eur. J. Intern. Med., 29, 71-77
DOI 10.1016/j.ejim.2016.01.001

Publications 2015

Bellavia D, Cataliotti A, Clemenza F, Baravoglia CH, Luca A, Traina M, Gridelli B, Bertani T, Burnett JC, Scardulla C (2015)
Long-Term Structural and Functional Myocardial Adaptations in Healthy Living Kidney Donors: A Pilot Study
PLoS One, 10 (11), e0142103
DOI 10.1371/journal.pone.0142103

Holditch SJ, Schreiber CA, Nini R, Tonne JM, Peng KW, Geurts A, Jacob HJ, Burnett JC, Cataliotti A, Ikeda Y (2015)
B-Type Natriuretic Peptide Deletion Leads to Progressive Hypertension, Associated Organ Damage, and Reduced Survival Novel Model for Human Hypertension
Hypertension, 66 (1), 199-210
DOI 10.1161/HYPERTENSIONAHA.115.05610

Rosjo H, Dahl MB, Jorgensen M, Roysland R, Brynildsen J, Cataliotti A, Christensen G, Hoiseth AD, Hagve TA, Omland T (2015)
Influence of Glycosylation on Diagnostic and Prognostic Accuracy of N-Terminal Pro-B-Type Natriuretic Peptide in Acute Dyspnea: Data from the Akershus Cardiac Examination 2 Study
Clin. Chem., 61 (8), 1087-1097
DOI 10.1373/clinchem.2015.239673

Publications 2014

Aspelin T, Eriksen M, Ilebekk A, Cataliotti A, Carlson CR, Lyberg T (2014)
beta-blockade abolishes the augmented cardiac tPA release induced by transactivation of heterodimerised bradykinin receptor-2 and beta(2)-adrenergic receptor in vivo
Thromb. Haemost., 112 (5), 951-959
DOI 10.1160/TH14-01-0059